Global Influenza Drugs and Vaccines Market Insights and Forecast to 2026
- BMR3911196
- 114 Pages
- June 2020
- Healthcare
Prior to COVID-19, the market for Influenza Drugs and Vaccines was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of XX% during 2021–2026, whereas post-COVID-19 scenario, the market for Influenza Drugs and Vaccines is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026. The solicitation of proposals by the governments and public–private companies across the world to mitigate the impact of the COVID-19 pandemic is the key factor propelling the growth of the Influenza Drugs and Vaccines market.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Influenza Drugs and Vaccines market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyzes the impact of Coronavirus COVID-19 on the Influenza Drugs and Vaccines industry.
Global Influenza Drugs and Vaccines Scope and Segment
Influenza Drugs and Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Influenza Drugs and Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.
The following manufacturers are covered in this report:
GlaxoSmithKline
Sanofi Pasteur
CSL Limited
Astrazeneca
Protein Sciences Corporation
Serum Institute Of India Pvt. Ltd.
Emergent Biosolutions
Emergent Biosolutions
BioCryst Pharmaceuticals.Inc.
Alvogen
ABPI
Influenza Drugs and Vaccines Breakdown Data by Type
Zanamivir
Oseltamivir Phosphate
Peramivir
Trivalent
Quadrivalent
Influenza Drugs and Vaccines Breakdown Data by Application
Hospitals
Research Laboratories
Pharmacies
Others
Regional and Country-level Analysis
The Influenza Drugs and Vaccines market is analysed and market size information is provided by regions (countries).
The key regions covered in the Influenza Drugs and Vaccines market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Influenza Drugs and Vaccines Market Share Analysis
1.1 Influenza Drugs and Vaccines Product Introduction
1.2 Market Segments
1.3 Key Influenza Drugs and Vaccines Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Influenza Drugs and Vaccines Market Size Growth Rate by Type
1.4.2 Zanamivir
1.4.3 Oseltamivir Phosphate
1.4.4 Peramivir
1.4.5 Trivalent
1.4.6 Quadrivalent
1.5 Market by Application
1.5.1 Global Influenza Drugs and Vaccines Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Research Laboratories
1.5.4 Pharmacies
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Influenza Drugs and Vaccines Market Size, Estimates and Forecasts
2.1.1 Global Influenza Drugs and Vaccines Revenue 2015-2026
2.1.2 Global Influenza Drugs and Vaccines Sales 2015-2026
2.2 Global Influenza Drugs and Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Influenza Drugs and Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Influenza Drugs and Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Influenza Drugs and Vaccines Competitor Landscape by Players
3.1 Influenza Drugs and Vaccines Sales by Manufacturers
3.1.1 Influenza Drugs and Vaccines Sales by Manufacturers (2015-2020)
3.1.2 Influenza Drugs and Vaccines Sales Market Share by Manufacturers (2015-2020)
3.2 Influenza Drugs and Vaccines Revenue by Manufacturers
3.2.1 Influenza Drugs and Vaccines Revenue by Manufacturers (2015-2020)
3.2.2 Influenza Drugs and Vaccines Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Influenza Drugs and Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Influenza Drugs and Vaccines Revenue in 2019
3.2.5 Global Influenza Drugs and Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Influenza Drugs and Vaccines Price by Manufacturers
3.4 Influenza Drugs and Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Influenza Drugs and Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Influenza Drugs and Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Influenza Drugs and Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Influenza Drugs and Vaccines Market Size by Type (2015-2020)
4.1.1 Global Influenza Drugs and Vaccines Sales by Type (2015-2020)
4.1.2 Global Influenza Drugs and Vaccines Revenue by Type (2015-2020)
4.1.3 Influenza Drugs and Vaccines Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Influenza Drugs and Vaccines Market Size Forecast by Type (2021-2026)
4.2.1 Global Influenza Drugs and Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global Influenza Drugs and Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 Influenza Drugs and Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Influenza Drugs and Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Influenza Drugs and Vaccines Market Size by Application (2015-2020)
5.1.1 Global Influenza Drugs and Vaccines Sales by Application (2015-2020)
5.1.2 Global Influenza Drugs and Vaccines Revenue by Application (2015-2020)
5.1.3 Influenza Drugs and Vaccines Price by Application (2015-2020)
5.2 Influenza Drugs and Vaccines Market Size Forecast by Application (2021-2026)
5.2.1 Global Influenza Drugs and Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global Influenza Drugs and Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global Influenza Drugs and Vaccines Price Forecast by Application (2021-2026)
6 North America
6.1 North America Influenza Drugs and Vaccines by Country
6.1.1 North America Influenza Drugs and Vaccines Sales by Country
6.1.2 North America Influenza Drugs and Vaccines Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Influenza Drugs and Vaccines Market Facts & Figures by Type
6.3 North America Influenza Drugs and Vaccines Market Facts & Figures by Application
7 Europe
7.1 Europe Influenza Drugs and Vaccines by Country
7.1.1 Europe Influenza Drugs and Vaccines Sales by Country
7.1.2 Europe Influenza Drugs and Vaccines Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Influenza Drugs and Vaccines Market Facts & Figures by Type
7.3 Europe Influenza Drugs and Vaccines Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Influenza Drugs and Vaccines by Region
8.1.1 Asia Pacific Influenza Drugs and Vaccines Sales by Region
8.1.2 Asia Pacific Influenza Drugs and Vaccines Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Influenza Drugs and Vaccines Market Facts & Figures by Type
8.3 Asia Pacific Influenza Drugs and Vaccines Market Facts & Figures by Application
9 Latin America
9.1 Latin America Influenza Drugs and Vaccines by Country
9.1.1 Latin America Influenza Drugs and Vaccines Sales by Country
9.1.2 Latin America Influenza Drugs and Vaccines Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Influenza Drugs and Vaccines Market Facts & Figures by Type
9.3 Central & South America Influenza Drugs and Vaccines Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Influenza Drugs and Vaccines by Country
10.1.1 Middle East and Africa Influenza Drugs and Vaccines Sales by Country
10.1.2 Middle East and Africa Influenza Drugs and Vaccines Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Influenza Drugs and Vaccines Market Facts & Figures by Type
10.3 Middle East and Africa Influenza Drugs and Vaccines Market Facts & Figures by Application
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Description and Business Overview
11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GlaxoSmithKline Influenza Drugs and Vaccines Products Offered
11.1.5 GlaxoSmithKline Related Developments
11.2 Sanofi Pasteur
11.2.1 Sanofi Pasteur Corporation Information
11.2.2 Sanofi Pasteur Description and Business Overview
11.2.3 Sanofi Pasteur Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Sanofi Pasteur Influenza Drugs and Vaccines Products Offered
11.2.5 Sanofi Pasteur Related Developments
11.3 CSL Limited
11.3.1 CSL Limited Corporation Information
11.3.2 CSL Limited Description and Business Overview
11.3.3 CSL Limited Sales, Revenue and Gross Margin (2015-2020)
11.3.4 CSL Limited Influenza Drugs and Vaccines Products Offered
11.3.5 CSL Limited Related Developments
11.4 Astrazeneca
11.4.1 Astrazeneca Corporation Information
11.4.2 Astrazeneca Description and Business Overview
11.4.3 Astrazeneca Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Astrazeneca Influenza Drugs and Vaccines Products Offered
11.4.5 Astrazeneca Related Developments
11.5 Protein Sciences Corporation
11.5.1 Protein Sciences Corporation Corporation Information
11.5.2 Protein Sciences Corporation Description and Business Overview
11.5.3 Protein Sciences Corporation Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Protein Sciences Corporation Influenza Drugs and Vaccines Products Offered
11.5.5 Protein Sciences Corporation Related Developments
11.6 Serum Institute Of India Pvt. Ltd.
11.6.1 Serum Institute Of India Pvt. Ltd. Corporation Information
11.6.2 Serum Institute Of India Pvt. Ltd. Description and Business Overview
11.6.3 Serum Institute Of India Pvt. Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Serum Institute Of India Pvt. Ltd. Influenza Drugs and Vaccines Products Offered
11.6.5 Serum Institute Of India Pvt. Ltd. Related Developments
11.7 Emergent Biosolutions
11.7.1 Emergent Biosolutions Corporation Information
11.7.2 Emergent Biosolutions Description and Business Overview
11.7.3 Emergent Biosolutions Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Emergent Biosolutions Influenza Drugs and Vaccines Products Offered
11.7.5 Emergent Biosolutions Related Developments
11.8 Emergent Biosolutions
11.8.1 Emergent Biosolutions Corporation Information
11.8.2 Emergent Biosolutions Description and Business Overview
11.8.3 Emergent Biosolutions Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Emergent Biosolutions Influenza Drugs and Vaccines Products Offered
11.8.5 Emergent Biosolutions Related Developments
11.9 BioCryst Pharmaceuticals.Inc.
11.9.1 BioCryst Pharmaceuticals.Inc. Corporation Information
11.9.2 BioCryst Pharmaceuticals.Inc. Description and Business Overview
11.9.3 BioCryst Pharmaceuticals.Inc. Sales, Revenue and Gross Margin (2015-2020)
11.9.4 BioCryst Pharmaceuticals.Inc. Influenza Drugs and Vaccines Products Offered
11.9.5 BioCryst Pharmaceuticals.Inc. Related Developments
11.10 Alvogen
11.10.1 Alvogen Corporation Information
11.10.2 Alvogen Description and Business Overview
11.10.3 Alvogen Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Alvogen Influenza Drugs and Vaccines Products Offered
11.10.5 Alvogen Related Developments
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Description and Business Overview
11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GlaxoSmithKline Influenza Drugs and Vaccines Products Offered
11.1.5 GlaxoSmithKline Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Influenza Drugs and Vaccines Market Estimates and Projections by Region
12.1.1 Global Influenza Drugs and Vaccines Sales Forecast by Regions 2021-2026
12.1.2 Global Influenza Drugs and Vaccines Revenue Forecast by Regions 2021-2026
12.2 North America Influenza Drugs and Vaccines Market Size Forecast (2021-2026)
12.2.1 North America: Influenza Drugs and Vaccines Sales Forecast (2021-2026)
12.2.2 North America: Influenza Drugs and Vaccines Revenue Forecast (2021-2026)
12.2.3 North America: Influenza Drugs and Vaccines Market Size Forecast by Country (2021-2026)
12.3 Europe Influenza Drugs and Vaccines Market Size Forecast (2021-2026)
12.3.1 Europe: Influenza Drugs and Vaccines Sales Forecast (2021-2026)
12.3.2 Europe: Influenza Drugs and Vaccines Revenue Forecast (2021-2026)
12.3.3 Europe: Influenza Drugs and Vaccines Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Influenza Drugs and Vaccines Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Influenza Drugs and Vaccines Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Influenza Drugs and Vaccines Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Influenza Drugs and Vaccines Market Size Forecast by Region (2021-2026)
12.5 Latin America Influenza Drugs and Vaccines Market Size Forecast (2021-2026)
12.5.1 Latin America: Influenza Drugs and Vaccines Sales Forecast (2021-2026)
12.5.2 Latin America: Influenza Drugs and Vaccines Revenue Forecast (2021-2026)
12.5.3 Latin America: Influenza Drugs and Vaccines Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Influenza Drugs and Vaccines Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Influenza Drugs and Vaccines Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Influenza Drugs and Vaccines Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Influenza Drugs and Vaccines Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Influenza Drugs and Vaccines Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Influenza Drugs and Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Influenza Drugs and Vaccines Market Segments
Table 2. Ranking of Global Top Influenza Drugs and Vaccines Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Influenza Drugs and Vaccines Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Zanamivir
Table 5. Major Manufacturers of Oseltamivir Phosphate
Table 6. Major Manufacturers of Peramivir
Table 7. Major Manufacturers of Trivalent
Table 8. Major Manufacturers of Quadrivalent
Table 9. Global Influenza Drugs and Vaccines Market Size Growth Rate by Application 2020-2026 (K MT)
Table 10. Global Influenza Drugs and Vaccines Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 11. Global Influenza Drugs and Vaccines Sales by Regions 2015-2020 (K MT)
Table 12. Global Influenza Drugs and Vaccines Sales Market Share by Regions (2015-2020)
Table 13. Global Influenza Drugs and Vaccines Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Influenza Drugs and Vaccines Sales by Manufacturers (2015-2020) (K MT)
Table 15. Global Influenza Drugs and Vaccines Sales Share by Manufacturers (2015-2020)
Table 16. Global Influenza Drugs and Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Influenza Drugs and Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Drugs and Vaccines as of 2019)
Table 18. Influenza Drugs and Vaccines Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Influenza Drugs and Vaccines Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Influenza Drugs and Vaccines Price (2015-2020) (USD/MT)
Table 21. Influenza Drugs and Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Influenza Drugs and Vaccines Product Type
Table 23. Date of International Manufacturers Enter into Influenza Drugs and Vaccines Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Influenza Drugs and Vaccines Sales by Type (2015-2020) (K MT)
Table 26. Global Influenza Drugs and Vaccines Sales Share by Type (2015-2020)
Table 27. Global Influenza Drugs and Vaccines Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Influenza Drugs and Vaccines Revenue Share by Type (2015-2020)
Table 29. Influenza Drugs and Vaccines Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 30. Global Influenza Drugs and Vaccines Sales by Application (2015-2020) (K MT)
Table 31. Global Influenza Drugs and Vaccines Sales Share by Application (2015-2020)
Table 32. North America Influenza Drugs and Vaccines Sales by Country (2015-2020) (K MT)
Table 33. North America Influenza Drugs and Vaccines Sales Market Share by Country (2015-2020)
Table 34. North America Influenza Drugs and Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Influenza Drugs and Vaccines Revenue Market Share by Country (2015-2020)
Table 36. North America Influenza Drugs and Vaccines Sales by Type (2015-2020) (K MT)
Table 37. North America Influenza Drugs and Vaccines Sales Market Share by Type (2015-2020)
Table 38. North America Influenza Drugs and Vaccines Sales by Application (2015-2020) (K MT)
Table 39. North America Influenza Drugs and Vaccines Sales Market Share by Application (2015-2020)
Table 40. Europe Influenza Drugs and Vaccines Sales by Country (2015-2020) (K MT)
Table 41. Europe Influenza Drugs and Vaccines Sales Market Share by Country (2015-2020)
Table 42. Europe Influenza Drugs and Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Influenza Drugs and Vaccines Revenue Market Share by Country (2015-2020)
Table 44. Europe Influenza Drugs and Vaccines Sales by Type (2015-2020) (K MT)
Table 45. Europe Influenza Drugs and Vaccines Sales Market Share by Type (2015-2020)
Table 46. Europe Influenza Drugs and Vaccines Sales by Application (2015-2020) (K MT)
Table 47. Europe Influenza Drugs and Vaccines Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Influenza Drugs and Vaccines Sales by Region (2015-2020) (K MT)
Table 49. Asia Pacific Influenza Drugs and Vaccines Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Influenza Drugs and Vaccines Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Influenza Drugs and Vaccines Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Influenza Drugs and Vaccines Sales by Type (2015-2020) (K MT)
Table 53. Asia Pacific Influenza Drugs and Vaccines Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Influenza Drugs and Vaccines Sales by Application (2015-2020) (K MT)
Table 55. Asia Pacific Influenza Drugs and Vaccines Sales Market Share by Application (2015-2020)
Table 56. Latin America Influenza Drugs and Vaccines Sales by Country (2015-2020) (K MT)
Table 57. Latin America Influenza Drugs and Vaccines Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Influenza Drugs and Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Influenza Drugs and Vaccines Revenue Market Share by Country (2015-2020)
Table 60. Latin America Influenza Drugs and Vaccines Sales by Type (2015-2020) (K MT)
Table 61. Latin America Influenza Drugs and Vaccines Sales Market Share by Type (2015-2020)
Table 62. Latin America Influenza Drugs and Vaccines Sales by Application (2015-2020) (K MT)
Table 63. Latin America Influenza Drugs and Vaccines Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Influenza Drugs and Vaccines Sales by Country (2015-2020) (K MT)
Table 65. Middle East and Africa Influenza Drugs and Vaccines Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Influenza Drugs and Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Influenza Drugs and Vaccines Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Influenza Drugs and Vaccines Sales by Type (2015-2020) (K MT)
Table 69. Middle East and Africa Influenza Drugs and Vaccines Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Influenza Drugs and Vaccines Sales by Application (2015-2020) (K MT)
Table 71. Middle East and Africa Influenza Drugs and Vaccines Sales Market Share by Application (2015-2020)
Table 72. GlaxoSmithKline Corporation Information
Table 73. GlaxoSmithKline Description and Major Businesses
Table 74. GlaxoSmithKline Influenza Drugs and Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 75. GlaxoSmithKline Product
Table 76. GlaxoSmithKline Recent Development
Table 77. Sanofi Pasteur Corporation Information
Table 78. Sanofi Pasteur Description and Major Businesses
Table 79. Sanofi Pasteur Influenza Drugs and Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 80. Sanofi Pasteur Product
Table 81. Sanofi Pasteur Recent Development
Table 82. CSL Limited Corporation Information
Table 83. CSL Limited Description and Major Businesses
Table 84. CSL Limited Influenza Drugs and Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 85. CSL Limited Product
Table 86. CSL Limited Recent Development
Table 87. Astrazeneca Corporation Information
Table 88. Astrazeneca Description and Major Businesses
Table 89. Astrazeneca Influenza Drugs and Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 90. Astrazeneca Product
Table 91. Astrazeneca Recent Development
Table 92. Protein Sciences Corporation Corporation Information
Table 93. Protein Sciences Corporation Description and Major Businesses
Table 94. Protein Sciences Corporation Influenza Drugs and Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 95. Protein Sciences Corporation Product
Table 96. Protein Sciences Corporation Recent Development
Table 97. Serum Institute Of India Pvt. Ltd. Corporation Information
Table 98. Serum Institute Of India Pvt. Ltd. Description and Major Businesses
Table 99. Serum Institute Of India Pvt. Ltd. Influenza Drugs and Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 100. Serum Institute Of India Pvt. Ltd. Product
Table 101. Serum Institute Of India Pvt. Ltd. Recent Development
Table 102. Emergent Biosolutions Corporation Information
Table 103. Emergent Biosolutions Description and Major Businesses
Table 104. Emergent Biosolutions Influenza Drugs and Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 105. Emergent Biosolutions Product
Table 106. Emergent Biosolutions Recent Development
Table 107. Emergent Biosolutions Corporation Information
Table 108. Emergent Biosolutions Description and Major Businesses
Table 109. Emergent Biosolutions Influenza Drugs and Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 110. Emergent Biosolutions Product
Table 111. Emergent Biosolutions Recent Development
Table 112. BioCryst Pharmaceuticals.Inc. Corporation Information
Table 113. BioCryst Pharmaceuticals.Inc. Description and Major Businesses
Table 114. BioCryst Pharmaceuticals.Inc. Influenza Drugs and Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 115. BioCryst Pharmaceuticals.Inc. Product
Table 116. BioCryst Pharmaceuticals.Inc. Recent Development
Table 117. Alvogen Corporation Information
Table 118. Alvogen Description and Major Businesses
Table 119. Alvogen Influenza Drugs and Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 120. Alvogen Product
Table 121. Alvogen Recent Development
Table 122. ABPI Corporation Information
Table 123. ABPI Description and Major Businesses
Table 124. ABPI Influenza Drugs and Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 125. ABPI Product
Table 126. ABPI Recent Development
Table 127. Global Influenza Drugs and Vaccines Sales Forecast by Regions (2021-2026) (K MT)
Table 128. Global Influenza Drugs and Vaccines Sales Market Share Forecast by Regions (2021-2026)
Table 129. Global Influenza Drugs and Vaccines Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 130. Global Influenza Drugs and Vaccines Revenue Market Share Forecast by Regions (2021-2026)
Table 131. North America: Influenza Drugs and Vaccines Sales Forecast by Country (2021-2026) (K MT)
Table 132. North America: Influenza Drugs and Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Europe: Influenza Drugs and Vaccines Sales Forecast by Country (2021-2026) (K MT)
Table 134. Europe: Influenza Drugs and Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 135. Asia Pacific: Influenza Drugs and Vaccines Sales Forecast by Region (2021-2026) (K MT)
Table 136. Asia Pacific: Influenza Drugs and Vaccines Revenue Forecast by Region (2021-2026) (US$ Million)
Table 137. Latin America: Influenza Drugs and Vaccines Sales Forecast by Country (2021-2026) (K MT)
Table 138. Latin America: Influenza Drugs and Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 139. Middle East and Africa: Influenza Drugs and Vaccines Sales Forecast by Country (2021-2026) (K MT)
Table 140. Middle East and Africa: Influenza Drugs and Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 141. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 142. Key Challenges
Table 143. Market Risks
Table 144. Main Points Interviewed from Key Influenza Drugs and Vaccines Players
Table 145. Influenza Drugs and Vaccines Customers List
Table 146. Influenza Drugs and Vaccines Distributors List
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Influenza Drugs and Vaccines Product Picture
Figure 2. Global Influenza Drugs and Vaccines Sales Market Share by Type in 2020 & 2026
Figure 3. Zanamivir Product Picture
Figure 4. Oseltamivir Phosphate Product Picture
Figure 5. Peramivir Product Picture
Figure 6. Trivalent Product Picture
Figure 7. Quadrivalent Product Picture
Figure 8. Global Influenza Drugs and Vaccines Sales Market Share by Application in 2020 & 2026
Figure 9. Hospitals
Figure 10. Research Laboratories
Figure 11. Pharmacies
Figure 12. Others
Figure 13. Influenza Drugs and Vaccines Report Years Considered
Figure 14. Global Influenza Drugs and Vaccines Market Size 2015-2026 (US$ Million)
Figure 15. Global Influenza Drugs and Vaccines Sales 2015-2026 (K MT)
Figure 16. Global Influenza Drugs and Vaccines Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Influenza Drugs and Vaccines Sales Market Share by Region (2015-2020)
Figure 18. Global Influenza Drugs and Vaccines Sales Market Share by Region in 2019
Figure 19. Global Influenza Drugs and Vaccines Revenue Market Share by Region (2015-2020)
Figure 20. Global Influenza Drugs and Vaccines Revenue Market Share by Region in 2019
Figure 21. Global Influenza Drugs and Vaccines Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Influenza Drugs and Vaccines Revenue in 2019
Figure 23. Influenza Drugs and Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Influenza Drugs and Vaccines Sales Market Share by Type (2015-2020)
Figure 25. Global Influenza Drugs and Vaccines Sales Market Share by Type in 2019
Figure 26. Global Influenza Drugs and Vaccines Revenue Market Share by Type (2015-2020)
Figure 27. Global Influenza Drugs and Vaccines Revenue Market Share by Type in 2019
Figure 28. Global Influenza Drugs and Vaccines Market Share by Price Range (2015-2020)
Figure 29. Global Influenza Drugs and Vaccines Sales Market Share by Application (2015-2020)
Figure 30. Global Influenza Drugs and Vaccines Sales Market Share by Application in 2019
Figure 31. Global Influenza Drugs and Vaccines Revenue Market Share by Application (2015-2020)
Figure 32. Global Influenza Drugs and Vaccines Revenue Market Share by Application in 2019
Figure 33. North America Influenza Drugs and Vaccines Sales Growth Rate 2015-2020 (K MT)
Figure 34. North America Influenza Drugs and Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Influenza Drugs and Vaccines Sales Market Share by Country in 2019
Figure 36. North America Influenza Drugs and Vaccines Revenue Market Share by Country in 2019
Figure 37. U.S. Influenza Drugs and Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 38. U.S. Influenza Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Influenza Drugs and Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 40. Canada Influenza Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Influenza Drugs and Vaccines Market Share by Type in 2019
Figure 42. North America Influenza Drugs and Vaccines Market Share by Application in 2019
Figure 43. Europe Influenza Drugs and Vaccines Sales Growth Rate 2015-2020 (K MT)
Figure 44. Europe Influenza Drugs and Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Influenza Drugs and Vaccines Sales Market Share by Country in 2019
Figure 46. Europe Influenza Drugs and Vaccines Revenue Market Share by Country in 2019
Figure 47. Germany Influenza Drugs and Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 48. Germany Influenza Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Influenza Drugs and Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 50. France Influenza Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Influenza Drugs and Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 52. U.K. Influenza Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Influenza Drugs and Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 54. Italy Influenza Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Influenza Drugs and Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 56. Russia Influenza Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Influenza Drugs and Vaccines Market Share by Type in 2019
Figure 58. Europe Influenza Drugs and Vaccines Market Share by Application in 2019
Figure 59. Asia Pacific Influenza Drugs and Vaccines Sales Growth Rate 2015-2020 (K MT)
Figure 60. Asia Pacific Influenza Drugs and Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Influenza Drugs and Vaccines Sales Market Share by Region in 2019
Figure 62. Asia Pacific Influenza Drugs and Vaccines Revenue Market Share by Region in 2019
Figure 63. China Influenza Drugs and Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 64. China Influenza Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Influenza Drugs and Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 66. Japan Influenza Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Influenza Drugs and Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 68. South Korea Influenza Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Influenza Drugs and Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 70. India Influenza Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Influenza Drugs and Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 72. Australia Influenza Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Influenza Drugs and Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 74. Taiwan Influenza Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Influenza Drugs and Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 76. Indonesia Influenza Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Influenza Drugs and Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 78. Thailand Influenza Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Influenza Drugs and Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 80. Malaysia Influenza Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Influenza Drugs and Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 82. Philippines Influenza Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Influenza Drugs and Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 84. Vietnam Influenza Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Influenza Drugs and Vaccines Market Share by Type in 2019
Figure 86. Asia Pacific Influenza Drugs and Vaccines Market Share by Application in 2019
Figure 87. Latin America Influenza Drugs and Vaccines Sales Growth Rate 2015-2020 (K MT)
Figure 88. Latin America Influenza Drugs and Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Influenza Drugs and Vaccines Sales Market Share by Country in 2019
Figure 90. Latin America Influenza Drugs and Vaccines Revenue Market Share by Country in 2019
Figure 91. Mexico Influenza Drugs and Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 92. Mexico Influenza Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Influenza Drugs and Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 94. Brazil Influenza Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Influenza Drugs and Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 96. Argentina Influenza Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Influenza Drugs and Vaccines Market Share by Type in 2019
Figure 98. Latin America Influenza Drugs and Vaccines Market Share by Application in 2019
Figure 99. Middle East and Africa Influenza Drugs and Vaccines Sales Growth Rate 2015-2020 (K MT)
Figure 100. Middle East and Africa Influenza Drugs and Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Influenza Drugs and Vaccines Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Influenza Drugs and Vaccines Revenue Market Share by Country in 2019
Figure 103. Turkey Influenza Drugs and Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 104. Turkey Influenza Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Influenza Drugs and Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 106. Saudi Arabia Influenza Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Influenza Drugs and Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 108. U.A.E Influenza Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Influenza Drugs and Vaccines Market Share by Type in 2019
Figure 110. Middle East and Africa Influenza Drugs and Vaccines Market Share by Application in 2019
Figure 111. North America Influenza Drugs and Vaccines Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 112. North America Influenza Drugs and Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe Influenza Drugs and Vaccines Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 114. Europe Influenza Drugs and Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific Influenza Drugs and Vaccines Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. Asia Pacific Influenza Drugs and Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America Influenza Drugs and Vaccines Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 118. Latin America Influenza Drugs and Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa Influenza Drugs and Vaccines Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 120. Middle East and Africa Influenza Drugs and Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed
Similar Reports
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
- Publish Date: February 26, 2018
- $5370
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
- Publish Date: May 29, 2018
- $5370
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...
- Publish Date: May 1, 2016
- $5370
